Viewing Study NCT00375349



Ignite Creation Date: 2024-05-05 @ 5:02 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00375349
Status: WITHDRAWN
Last Update Posted: 2016-09-30
First Post: 2006-09-11

Brief Title: Non Alcoholic Fatty Liver Disease Influence of Statin Therapy
Sponsor: Shaare Zedek Medical Center
Organization: Shaare Zedek Medical Center

Study Overview

Official Title: None
Status: WITHDRAWN
Status Verified Date: 2016-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Aim

1 To determine the prevalence of fatty liver in a cohort of patients hospitalized with chest pain in the Cardiology department
2 To assess the effect of statins on the prevalence of fatty liver by a cross sectional survey of patients hospitalized with chest pain
Detailed Description: Consecutive patients hospitalized with chest pain will be recruited at the cardiology department Patients with an inflammatory condition recent infection or history of alcoholism will be excluded After signing an informed consent each patient will undergo an ultrasound examination for diagnosis of fatty liver Information regarding BMI hypertension and use of medications will be collected on each patient Blood samples for fasting glucose hemoglobin A1C lipid profile ESR and CRP and liver function tests will be collected from each participant Prevalence of fatty liver in patients who have been taking statins for 6 months or more statins will be compared to patients who have been taking statins for a lesser period and to those who do have not taken statins using a multivariate regression analysis

Serum samples will be frozen and kept for future ongoing research

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None